122 related articles for article (PubMed ID: 3821915)
21. [Radioimmunoimaging of malignant melanoma with In-111 labeled monoclonal antibody 96.5 and ZME-0.18].
Ishii K; Nishiyama S; Oyamada H; Endo K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1194-203. PubMed ID: 2730019
[TBL] [Abstract][Full Text] [Related]
22. Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma.
Fisher B; Packard BS; Read EJ; Carrasquillo JA; Carter CS; Topalian SL; Yang JC; Yolles P; Larson SM; Rosenberg SA
J Clin Oncol; 1989 Feb; 7(2):250-61. PubMed ID: 2644399
[TBL] [Abstract][Full Text] [Related]
23. Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection.
Halpern SE; Haindl W; Beauregard J; Hagan P; Clutter M; Amox D; Merchant B; Unger M; Mongovi C; Bartholomew R
Radiology; 1988 Aug; 168(2):529-36. PubMed ID: 3393677
[TBL] [Abstract][Full Text] [Related]
24. Clinical use of a standard kit-preparation of radiolabeled monoclonal antibody 96.5 in the diagnostic imaging of metastatic melanoma.
Saleh MN; Miller DM; Peterson L; Russell CD; Unger MW; Urist MM; Wheeler RH; LoBuglio AF
J Clin Oncol; 1988 Jun; 6(6):1059-65. PubMed ID: 3373261
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of monoclonal antibody binding to melanoma with single dose radiation or hyperthermia.
Stickney DR; Gridley DS; Kirk GA; Slater JM
NCI Monogr; 1987; (3):47-52. PubMed ID: 3821918
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients.
Hnatowich DJ; Griffin TW; Kosciuczyk C; Rusckowski M; Childs RL; Mattis JA; Shealy D; Doherty PW
J Nucl Med; 1985 Aug; 26(8):849-58. PubMed ID: 3861793
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts.
Longley C; Furmanski P; Dienhart DG; Lear J; Bloedow D; Kasliwal R; Bunn PA
Cancer Res; 1990 Sep; 50(18):5954-61. PubMed ID: 2393864
[TBL] [Abstract][Full Text] [Related]
28. Uptake of indium-111-labeled monoclonal antibody ZME-018 as a function of tumor size in a patient with melanoma.
Macey DJ; Denardo SJ; Denardo GL; Goodnight JK; Unger MW
Am J Physiol Imaging; 1988; 3(1):1-6. PubMed ID: 3390350
[TBL] [Abstract][Full Text] [Related]
29. Immunoscintigraphy with 123I, 99mTc and 111In-labelled F(ab')2 fragments of monoclonal antibodies to a human high molecular weight-melanoma associated antigen.
Buraggi GL; Callegaro L; Turrin A; Cascinelli N; Attili A; Emanuelli H; Gasparini M; Deleide G; Plassio G; Dovis M
J Nucl Med Allied Sci; 1984; 28(4):283-95. PubMed ID: 6535835
[No Abstract] [Full Text] [Related]
30. Immunoscintigraphy and pharmacokinetics of indium-111-labeled ZME-018 monoclonal antibody in patients with malignant melanoma.
Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Arano Y; Miyachi Y; Kashihara-Sawami M; Imamura S
Jpn J Cancer Res; 1988 Aug; 79(8):973-81. PubMed ID: 3141332
[TBL] [Abstract][Full Text] [Related]
31. Lymphoscintigraphy in melanoma: initial evaluation of a low protein dose monoclonal antibody cocktail.
Wahl RL; Liebert M; Headington J; Wilson BS; Shulkin BL; Johnson JW; Mallette S; Natale RB; Coon W; East M
Cancer Res; 1990 Feb; 50(3 Suppl):941s-948s. PubMed ID: 2297746
[TBL] [Abstract][Full Text] [Related]
32. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture.
Larson SM
Radiology; 1987 Nov; 165(2):297-304. PubMed ID: 3498971
[TBL] [Abstract][Full Text] [Related]
33. [Clinical trials of melanoma imaging with In-111-labeled monoclonal antibody 96.5].
Oyamada H; Ishihara K; Hayasaka K; Terui S; Fukukita H; Tateno Y
Kaku Igaku; 1986 Nov; 23(11):1595-611. PubMed ID: 3820850
[No Abstract] [Full Text] [Related]
34. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.
Buraggi GL; Callegaro L; Mariani G; Turrin A; Cascinelli N; Attili A; Bombardieri E; Terno G; Plassio G; Dovis M
Cancer Res; 1985 Jul; 45(7):3378-87. PubMed ID: 4005860
[TBL] [Abstract][Full Text] [Related]
35. Interferon-induced changes in pharmacokinetics and tumor uptake of 111In-labeled antimelanoma antibody 96.5 in melanoma patients.
Rosenblum MG; Lamki LM; Murray JL; Carlo DJ; Gutterman JU
J Natl Cancer Inst; 1988 Apr; 80(3):160-5. PubMed ID: 3346909
[TBL] [Abstract][Full Text] [Related]
36. Comparative clinical pharmacology of [111In]-labeled murine monoclonal antibodies.
Rosenblum MG; Murray JL; Lamki L; David G; Carlo D
Cancer Chemother Pharmacol; 1987; 20(1):41-7. PubMed ID: 3621452
[TBL] [Abstract][Full Text] [Related]
37. [Radioimmunoscintigraphy with a 99mTc-labeled F(ab')2 fragment of a monoclonal antibody (HMW-MAA 225.28S) in 71 patients with malignant melanoma].
Rentsch M; Cerny T; Geiger L; Gerber H; Brunner KW; Rösler H; Nachbur B
Schweiz Med Wochenschr; 1989 Oct; 119(40):1382-5. PubMed ID: 2552577
[TBL] [Abstract][Full Text] [Related]
38. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.
Siccardi AG; Buraggi GL; Callegaro L; Mariani G; Natali PG; Abbati A; Bestagno M; Caputo V; Mansi L; Masi R
Cancer Res; 1986 Sep; 46(9):4817-22. PubMed ID: 3731128
[TBL] [Abstract][Full Text] [Related]
39. Imaging of melanoma with L-131-labeled monoclonal antibodies.
Larson SM; Brown JP; Wright PW; Carrasquillo JA; Hellström I; Hellström KE
J Nucl Med; 1983 Feb; 24(2):123-9. PubMed ID: 6822875
[TBL] [Abstract][Full Text] [Related]
40. A comparison of the cyclic anhydride and mixed anhydride methods for 111In-DTPA chelation to monoclonal antibodies.
Wang TS; Srivastava SC; Fawwaz RA; Giacomini P; Ferrone S; Richards P; Hardy M; Alderson PO
Nuklearmedizin; 1984 Aug; 23(4):193-5. PubMed ID: 6483630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
